MedTrace Logo

Can Virtual Reality Exercise Help Restore Both Body and Mind in Chronic Low Back Pain

NCT07207083 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-12-05

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if an immersive virtual reality (VR) exercise program can help reduce back pain and improve physical function and psychological well-being in adults with chronic low back pain.

The main questions it aim to answer are

* Does the virtual reality (VR) exercise reduce back pain?
* Does it lead to positive changes in how participants perceive pain?
* Does it improve back flexibility and reduce disability in daily activities?
* Does it help reduce the fear of movement and negative thoughts related to pain? Method Wear a Meta Quest 3s device and participate in a 15-minute virtual reality exercise program called 'FitXR'.

Be evaluated for their back pain, sensory test, range of motion, and level of disability in daily life before and after the exercise program.

Complete questionnaires about their thoughts and feelings regarding their pain and movement.

Conditions

  • Virtual Reality
  • Kinesiophobia
  • Chronic Low Back Pain (CLBP)
  • Central Sensitization
  • Fear of Movement

Interventions

BEHAVIORAL

Immersive Virtual Reality-based Exercise (FitXR, Meta Quest 3s)

participants assigned to the intervention group will perform a 15-minute immersive virtual reality (VR) exercise program using the FitXR application on the Meta Quest 3s headset. This program provides interactive, visually immersive exercise tasks designed to engage participants in physical activity while reducing fear of movement and enhancing functional recovery.

BEHAVIORAL

Conventional Exercise Program (Matched Exercise, without VR)

Participants assigned to this arm will perform the same 15-minute exercise program without virtual reality equipment. This allows comparison between immersive VR-based exercise and conventional exercise of equivalent intensity and duration.

Sponsors & Collaborators

  • dongmin kang

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-28
Primary Completion
2025-12-16
Completion
2025-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07207083 on ClinicalTrials.gov